Search Results - "Axelrod, D.A."

Systematic Evaluation of Pancreas Allograft Quality, Outcomes and Geographic Variation in Utilization by Axelrod, D. A., Sung, R. S., Meyer, K. H., Wolfe, R. A., Kaufman, D. B.

“…Pancreas allograft acceptance is markedly more selective than other solid organs. The number of pancreata recovered is insufficient to meet the demand for…”
Get full text

The Changing Financial Landscape of Renal Transplant Practice: A National Cohort Analysis by Axelrod, D. A., Schnitzler, M. A., Xiao, H., Naik, A. S., Segev, D. L., Dharnidharka, V. R., Brennan, D. C., Lentine, K. L.

“…Kidney transplantation has become more resource intensive as recipient complexity has increased and average donor quality has diminished over time. A national…”
Get full text

Balancing Accountable Care With Risk Aversion: Transplantation as a Model by Axelrod, D. A.

“…Transplantation is widely regarded as a model of accountability and transparency in healthcare; however, failure to accurately measure and report appropriate…”
Get full text

The impact of direct‐acting antiviral agents on liver and kidney transplant costs and outcomes by Axelrod, D. A., Schnitzler, M. A., Alhamad, T., Gordon, F., Bloom, R. D., Hess, G. P., Xiao, H., Nazzal, M., Segev, D. L., Dharnidharka, V. R., Naik, A. S., Lam, N. N., Ouseph, R., Kasiske, B. L., Durand, C. M., Lentine, K. L.

“…Direct‐acting antiviral medications (DAAs) have revolutionized care for hepatitis C positive (HCV+) liver (LT) and kidney (KT) transplant recipients…”
Get full text

Measuring What Matters by Axelrod, D. A., Schold, J.

“…The current system to assess transplant center performances needs refinement to ensure that reduced access to transplantation is not an unintended consequence…”
Get full text

Prescription opioid use before and after kidney transplant: Implications for posttransplant outcomes by Lentine, K. L., Lam, N. N., Naik, A. S., Axelrod, D. A., Zhang, Z., Dharnidharka, V. R., Hess, G. P., Segev, D. L., Ouseph, R., Randall, H., Alhamad, T., Devraj, R., Gadi, R., Kasiske, B. L., Brennan, D. C., Schnitzler, M. A.

“…Evolving literature suggests that the epidemic of prescription opioid use affects the transplant population. We examined a novel database wherein national U.S…”
Get full text

Utilizing High‐Risk Kidneys—Risks, Benefits, and Unintended Consequences? by Axelrod, D. A., Friedewald, J. J.

“…While the increased transplantation of high kidney donor profile kidneys will benefit appropriate patients, transplant centers remain reasonably concerned…”
Get full text

OPTN/SRTR 2016 Annual Data Report: Economics by Schnitzler, M. A., Skeans, M. A., Axelrod, D. A., Lentine, K. L., Randall, H. B., Snyder, J. J., Israni, A. K., Kasiske, B. L.

“…Medicare costs vary for solid organ transplant recipients by outcome: survival with graft function, survival with graft failure, and death. Average per‐person…”
Get full text

MELD Exceptions and Rates of Waiting List Outcomes by Massie, A. B., Caffo, B., Gentry, S. E., Hall, E. C., Axelrod, D. A., Lentine, K. L., Schnitzler, M. A., Gheorghian, A., Salvalaggio, P. R., Segev, D. L.

“…Model for End‐stage Liver Disease (MELD)‐based allocation of deceased donor livers allows exceptions for patients whose score may not reflect their true…”
Get full text

Addressing Geographic Disparities in Liver Transplantation Through Redistricting by Gentry, S. E., Massie, A. B., Cheek, S. W., Lentine, K. L., Chow, E. H., Wickliffe, C. E., Dzebashvili, N., Salvalaggio, P. R., Schnitzler, M. A., Axelrod, D. A., Segev, D. L.

“…Severe geographic disparities exist in liver transplantation; for patients with comparable disease severity, 90‐day transplant rates range from 18% to 86% and…”
Get full text

Center practice drives variation in choice of US kidney transplant induction therapy: a retrospective analysis of contemporary practice by Dharnidharka, Vikas R, Naik, Abhijit S, Axelrod, David A, Schnitzler, Mark A, Zhang, Zidong, Bae, Sunjae, Segev, Dorry L, Brennan, Daniel C, Alhamad, Tarek, Ouseph, Rosemary, Lam, Ngan N, Nazzal, Mustafa, Randall, Henry, Kasiske, Bertram L, McAdams-Demarco, Mara, Lentine, Krista L

“…To assess factors that influence the choice of induction regimen in contemporary kidney transplantation, we examined center-identified, national transplant…”
Get more information

Kidney and Pancreas Transplantation in the United States, 1999–2008: The Changing Face of Living Donation by Axelrod, D. A., McCullough, K. P., Brewer, E. D., Becker, B. N., Segev, D. L., Rao, P. S.

“…The waiting list for kidney transplantation continued to grow between 1999 and 2008, from 41 177 to 76 089 candidates. However, active candidates represented…”
Get full text

National Variation in Use of Immunosuppression for Kidney Transplantation: A Call for Evidence‐Based Regimen Selection by Axelrod, D. A., Naik, A. S., Schnitzler, M. A., Segev, D. L., Dharnidharka, V. R., Brennan, D. C., Bae, S., Chen, J., Massie, A., Lentine, K. L.

“…Immunosuppression management in kidney transplantation has evolved to include an increasingly diverse choice of medications. Although informed by patient and…”
Get full text

Improving Access to Liver Care Across the Continuum of Care: Opportunities and Challenges by Axelrod, D. A., Lentine, K. L.

“…Evaluation of access to care for end‐stage liver disease reveals significant variation nationally, but the solution to this variation does not necessarily lie…”
Get full text

Changing Our Prior Assumptions: Adapting to New Bayesian Transplant Center Report Cards by Schold, J. D., Axelrod, D. A.

“…The use of Bayesian methodology to evaluate center performance has both potential benefits and drawbacks that the transplant community will need to carefully…”
Get full text

OPTN/SRTR 2019 Annual Data Report: Econ by Schnitzler, M.A., Miller, J., Skeans, M.A., Axelrod, D.A., Lentine, K.L., Randall, H.B., Snyder, J.J., Israni, A.K., Kasiske, B.L.

“…Resource utilization metrics vary widely across solid organ transplant modalities. Average length of stay (LOS) for kidney transplant has declined by 15.1%,…”
Get full text

Variation in Biliary Complication Rates Following Liver Transplantation: Implications for Cost and Outcome by Axelrod, D. A., Dzebisashvili, N., Lentine, K. L., Xiao, H., Schnitzler, M., Tuttle‐Newhall, J. E., Segev, D. L.

“…Although biliary complications (BCs) have a significant impact on the outcome of liver transplantation (LT), variation in BC rates among transplant centers has…”
Get full text

Prescription Opioid Use Before and After Kidney Transplant: Implications for Post-transplant Outcomes by Lentine, K.L., Lam, N.N., Naik, A.S., Axelrod, D.A., Zhang, Z., Dharnidharka, V.R., Hess, G.P., Segev, D.L., Ouseph, R., Randall, H., Alhamad, T., Devraj, R., Gadi, R., Kasiske, B.L., Brennan, D.C., Schnitzler, M.A.

“…Evolving literature suggests that the epidemic of prescription opioid use affects the transplant population. We examined a novel database wherein national U.S…”
Get full text

Assessing Variation in the Costs of Care Among Patients Awaiting Liver Transplantation by Axelrod, D. A., Dzebisashvili, N., Lentine, K., Segev, D. L., Dickson, R., Tuttle‐Newhall, E., Freeman, R., Schnitzler, M.

“…Previous economic analyses of liver transplantation have focused on the cost of the transplant and subsequent care. Accurate characterization of the…”
Get full text

Economics by Schnitzler, M.A., Valapour, M., Skeans, M.A., Axelrod, D.A., Lentine, K.L., Randall, H.B., Snyder, J.J., Israni, A.K., Kasiske, B.L.

Get full text